Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change. (Source: Various authors, Annals of Internal Medicine, Aug. 4, 2009) […]
Innovative Pricing Agreements to Enhance Access Prospects
Manufacturers, in more countries, are proposing risk-sharing and value-based schemes more often. […]
Federal Coordinating Council for Comparative Effectiveness Research (Report to the President and the Congress)
77 page report with definition, criteria, infrastructure, strategic framework, priorities, etc. […]
Comparative Effectiveness Research Funding on HHS Website
HHS seeks input on approaches to developing a CER Inventory that capture ongoing and existing CER in the United States. The inventory will be accessible to the public, including patients, clinicians, and policymakers, through a web-based system. […]
Comparative Effectiveness: Ongoing Issues and Physician Perspective Presentation by MedPAC
Now an analysis of findings from six focus groups commissioned by the Medicare Payment Advisory Commission, or MedPAC, finds that although physicians think comparative effectiveness research studies are a good idea, their support for such studies depends on a number of factors. […]
Evidenced-based Medicine Workbook
Evidence-based Medicine Workbook, Finding and applying the best research evidence to improve patient care. (Source: Glasziou, Del Mar, Salsbury, BMJ Books, September 2009) […]
Healthcare Debate – The Economist
This house believes that the widespread use of comparative effectiveness reviews and cost/benefit analyses will stifle medical innovation and lead to an unacceptable rationing of health care. (Source: The Economist, October 2009) […]
Baucus’s Bill and the Long Road to Reform
"...the administration considers Baucus’s bill the most promising vehicle for crafting a compromise, because it is less costly than the alternatives approved by four other congressional committees and is the most palatable to influential private stakeholders." (Source: Iglehart JK, NEJM, September […]
Assessing the Need to Update Comparative Effectiveness Research Reviews
Sign up to receive draft methods.(Source: AHRQ, Nov. 2009) […]
Evidence in Medicine: Correlation and Causation
First in a series of articles to discuss how to use evidence to arrive at reliable scientific conclusions? (Source Steven Novella, Science-Based Medicine, Nov. 18, 2009) […]
CEA Registry Blog
Welcome to the CEA Registry Blog by the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. We have developed this blog to encourage interactivity among our users by allowing readers to post comments and […]
Industry Influence on Comparative-Effectiveness Research Funded through Health Care Reform
Further investment in and analysis of comparative effectiveness is required for health care reform. […]
Update on Comparative Effectiveness and Health Information Technology Legislation and Policy Developments, and Their Impact on Pharmacoeconomics
Quality Improvement In Cost Effectiveness Research: ISPOR PPT Presentation
Debate about Funding Comparative-Effectiveness Research, by J. Avorn
"The proposal to include $1.1 billion for comparative-effectiveness research (CER) in the federal stimulus package encountered a vigorous and well-coordinated backlash. The campaign to gut this funding ultimately failed, but the debate it engendered and the resonance of the opposition's arguments in […]
Does Comparative-Effectiveness Research Threaten Personalized Medicine? by Garber and Tunis
"The American Reinvestment and Recovery Act gives comparative-effectiveness research (CER) a large boost in funding over the next 2 years. Despite a consensus that better information about the relative effectiveness of different medical interventions is needed to improve the quality and value of […]
The Neglected Purpose of Comparative-Effectiveness Research, by Naik and Petersen
Comparison is Key to Lower Costs, Better Outcomes from Medications
Patients can expect significant savings and better outcomes from their prescription medications when health care professionals use comparative effectiveness research, according to researchers at the University of Illinois at Chicago. […]
Drug Effectiveness Reveiw Project
DERP is a collaboration of public entities (the Center for Evidence-based Policy and the Oregon Evidence-based Practice Center) who have joined together to produce systematic, evidence-based reviews of the comparative effectiveness and safety of drugs in many widely used drug classes, and to apply […]
Cochrane Collaboration
International network of more than 28,000 dedicated people from over 100 countries. We work together to help health care providers, policy-makers, patients, their advocates and carers, make well-informed decisions about health care, based on the best available research evidence, by preparing, […]
Disease Management ROI: Benchmarks, Metrics, and Case Studies for Success
AHRQ Comparative Effectiveness Resources
Variety of White Papers, News, Methods Guides, and Databases to facilitate Comparative Effectiveness. […]
Cost Effectiveness Analysis (CEA) Registry
Provides public electronic access to a comprehensive database of cost-effectiveness ratios in the published literature. Its goals are to find opportunities for targeting resources to save lives and improve health and to move towards standardization of cost-effectiveness methodology in the field. […]
Use of Comparative Effectiveness Research in Drug Coverage and Pricing Decisions: A Six-Country Comp
This issue brief comparatively examines the use of CER across six countries […]
Groundwork for Methods Guide To Compare Medical Tests
